These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 32761505)

  • 21. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
    Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
    Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bidirectional Enhancement of Cell Proliferation Between Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cells and Choroid Plexus in a Cell-Based Therapy Model of Ischemic Stroke.
    Wu MR; Lee CH; Hsiao JK
    Int J Nanomedicine; 2020; 15():9181-9195. PubMed ID: 33239875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke.
    Zhou L; Zhu H; Bai X; Huang J; Chen Y; Wen J; Li X; Wu B; Tan Y; Tian M; Ren J; Li M; Yang Q
    Stem Cell Res Ther; 2022 May; 13(1):195. PubMed ID: 35551643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.
    Behzadifard M; Aboutaleb N; Dolatshahi M; Khorramizadeh M; Mirshekari Jahangiri H; Kord Z; Nazarinia D
    Neurochem Res; 2023 May; 48(5):1280-1292. PubMed ID: 36581731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of 3D MSC/HUVEC spheroids with neuroprotective and proangiogenic potentials ameliorates ischemic stroke brain injury.
    Hsu TW; Lu YJ; Lin YJ; Huang YT; Hsieh LH; Wu BH; Lin YC; Chen LC; Wang HW; Chuang JC; Fang YQ; Huang CC
    Biomaterials; 2021 May; 272():120765. PubMed ID: 33780686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Efficacy and Migration of Mesenchymal Stem Cells after Intracerebral Transplantation in Rats with Experimental Ischemic Stroke.
    Namestnikova DD; Gubskiy IL; Cherkashova EA; Sukhinich KK; Melnikov PA; Gabashvili AN; Kurilo VV; Chekhonin VP; Gubsky LV; Yarygin KN
    Bull Exp Biol Med; 2023 May; 175(1):116-125. PubMed ID: 37336809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.
    Cunningham CJ; Redondo-Castro E; Allan SM
    J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke.
    Dharmasaroja P
    J Clin Neurosci; 2009 Jan; 16(1):12-20. PubMed ID: 19017556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal Stem Cell-Mediated Mitochondrial Transfer: a Therapeutic Approach for Ischemic Stroke.
    Lu M; Guo J; Wu B; Zhou Y; Wu M; Farzaneh M; Khoshnam SE
    Transl Stroke Res; 2021 Apr; 12(2):212-229. PubMed ID: 32975692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation.
    Huang Y; Wang J; Cai J; Qiu Y; Zheng H; Lai X; Sui X; Wang Y; Lu Q; Zhang Y; Yuan M; Gong J; Cai W; Liu X; Shan Y; Deng Z; Shi Y; Shu Y; Zhang L; Qiu W; Peng L; Ren J; Lu Z; Xiang AP
    Theranostics; 2018; 8(21):5929-5944. PubMed ID: 30613272
    [No Abstract]   [Full Text] [Related]  

  • 31. iTRAQ-based proteomic analysis after mesenchymal stem cell line transplantation for ischemic stroke.
    Mitaki S; Nagai A; Wada Y; Onoda K; Md Sheikh A; Adachi E; Matsumoto KI; Yamaguchi S
    Brain Res; 2020 Sep; 1742():146900. PubMed ID: 32445714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salidroside-pretreated mesenchymal stem cells contribute to neuroprotection in cerebral ischemic injury in vitro and in vivo.
    Zhou L; Yao P; Jiang L; Wang Z; Ma X; Wen G; Yang J; Zhou B; Yu Q
    J Mol Histol; 2021 Dec; 52(6):1145-1154. PubMed ID: 34570327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The exo-microRNA (miRNA) signaling pathways in pathogenesis and treatment of stroke diseases: Emphasize on mesenchymal stem cells (MSCs).
    Farahmand Y; Nabiuni M; Vafaei Mastanabad M; Sheibani M; Mahmood BS; Obayes AM; Asadi F; Davallou R
    Cell Biochem Funct; 2024 Mar; 42(2):e3917. PubMed ID: 38379232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke.
    Lee JY; Kim E; Choi SM; Kim DW; Kim KP; Lee I; Kim HS
    Sci Rep; 2016 Sep; 6():33038. PubMed ID: 27609711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats.
    Gutiérrez-Fernández M; Rodríguez-Frutos B; Alvarez-Grech J; Vallejo-Cremades MT; Expósito-Alcaide M; Merino J; Roda JM; Díez-Tejedor E
    Neuroscience; 2011 Feb; 175():394-405. PubMed ID: 21144885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke.
    Salehi MS; Pandamooz S; Safari A; Jurek B; Tamadon A; Namavar MR; Dianatpour M; Dargahi L; Azarpira N; Fattahi S; Shid Moosavi SM; Keshavarz S; Khodabandeh Z; Zare S; Nazari S; Heidari M; Izadi S; Poursadeghfard M; Borhani-Haghighi A
    CNS Neurosci Ther; 2020 Jul; 26(7):670-681. PubMed ID: 32281225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia and interleukin-1-primed mesenchymal stem/stromal cells as novel therapy for stroke.
    Salaudeen MA; Allan S; Pinteaux E
    Hum Cell; 2024 Jan; 37(1):154-166. PubMed ID: 37987924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.
    Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.
    Nam HS; Kwon I; Lee BH; Kim H; Kim J; An S; Lee OH; Lee PH; Kim HO; Namgoong H; Kim YD; Heo JH
    PLoS One; 2015; 10(12):e0144218. PubMed ID: 26637168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.